Vein illuminator market seen topping $103 billion by 2030

The Business Research Company says the vein illuminator market is growing fast on rising IV procedures, chronic disease cases and demand for portable imaging tools. The report puts the market at $43.42 billion in 2026 and forecasts $103.74 billion by 2030.

Why it matters: - Vein illuminators help clinicians find veins faster and more accurately during procedures. - Better vein visibility can improve patient comfort and reduce needlestick injuries. - Demand is rising as hospitals, emergency care, outpatient care and home care expand use of the devices.

What happened: - The Business Research Company released a global vein illuminator market report on Sept. 3, 2026. - The report estimates the market will grow from $34.88 billion in 2025 to $43.42 billion in 2026. - The report forecasts the market will reach $103.74 billion by 2030. - The company says the market is expanding because of more intravenous procedures, more blood collection activity, wider hospital and emergency service use, stronger focus on patient comfort and more portable medical imaging devices. - The report defines a vein illuminator, also called a vein visualization device, as a near-infrared imaging tool that detects and maps veins beneath the skin. - The report says the technology helps healthcare professionals locate veins more efficiently and improve the success rate of intravenous procedures.

The details: - The report points to wider adoption in outpatient and emergency care settings as a major growth driver. - The report also cites increased focus on patient safety and accuracy during procedures. - The forecast includes growth from home and ambulatory care services. - The report flags integration of AI-based visualization tools as an emerging trend. - Other trends include near-infrared vein visualization devices, portable and handheld models, AI-assisted imaging algorithms and use in difficult venous access cases. - Chronic disease is identified as a key demand driver because patients with long-term illnesses often need blood tests and intravenous therapies. - In June 2024, the UK National Health Service reported 3,615,330 people registered with general practitioners had non-diabetic hyperglycemia or pre-diabetes in 2023, up 18% from 3,065,825 in 2022. - North America held the largest share of the vein illuminator market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - The company offers a free sample report and the full market report online through its website. - More information is available in the full report and a free sample.

Between the lines: - The forecast suggests the market is moving from a niche procedure aid toward a broader patient-care tool tied to multiple care settings. - AI and portability stand out as the main product shifts, which points to buyers looking for faster workflow and easier deployment. - Chronic disease trends add a structural demand base because difficult venous access is common in patients who need repeated treatment.

What's next: - Growth is expected to continue through 2030 as clinics and hospitals adopt more visualization tools. - The strongest gains may come from emergency care, outpatient treatment, ambulatory services and home care. - Vendors are likely to keep pushing handheld devices and AI-assisted imaging to differentiate products. - The report's regional split suggests North America remains the lead market while other regions offer expansion opportunities.